-
Mindfulness-based stress reduction (MBSR) was investigated as an intervention for fibromyalgia patients in a 3-armed randomized controlled trial using health-related quality of life at the end of 2 months as the primary outcome. While the study did not support the efficacy of MBSR for the treatment of FM for this outcome, some secondary outcome variables demonstrated improvement.
-
Results of this 8-week clinical trial demonstrated the efficacy of Lactobacillus rhamnosus strain GG (LGG) in reducing the frequency and severity of pain in children with irritable bowel syndrome or functional abdominal pain. Benefits persisted for 8 weeks after cessation of treatment. Additionally, small intestinal permeability was decreased in children with IBS treated with LGG.
-
In this exquisite set of methodical laboratory investigations, researchers tested whether adenosine might play a pivotal role in the analgesic effects associated with acupuncture. Their results suggest that the search for a mechanism of action behind this traditional therapy may be near its end.
-
Coenzyme q10 (coq10) has been recommended for a wide range of cardiac conditions.
-
The ECG shows sinus rhythm at 85/minute. The PR interval is normal. The QRS duration is upper normal (half a large box, but not more) and the QT interval is upper normal (about half the R-R interval, with a QTc ≈ 0.44 second).
-
It has been recognized for more than a decade that most patients with IBS have abnormal lactulose hydrogen breath tests results, consistent with small bowel bacterial overgrowth.
-
Brief behavioral intervention significantly relieved insomnia in a group of older adults.
-
The risk of future cardiovascular events in patients with an acute coronary syndrome (ACS) was lowest when the BP was in the range of approximately 130-140 mmHg systolic and 80-90 mm Hg diastolic and became highest as the blood pressure became lower; in fact, a blood pressure less than 110/70 mm Hg may actually be dangerous.
-
The fda has approved a new formulation of fentanyl for the management of breakthrough pain in cancer patients.
-
These reports originally appeared in the February issue of Neurology Alert. At that time it was peer reviewed by M. Flint Beal, MD, Anne Parrish Titzel Professor, Department of Neurology and Neuroscience, Weill Cornell Medical Center, New York, NY. Dr. Beal reports no financial relationship to this field of study.
